药学学报, 2021, 56(10): 2735-2741
引用本文:
张永雪, 蒲泽瑶, 安亚婷, 张薇, 王艺颖, 郝瀚, 张会然, 张海林, 杜肖娜. PDI在脊髓侧索硬化症中的研究进展[J]. 药学学报, 2021, 56(10): 2735-2741.
ZHANG Yong-xue, PU Ze-yao, AN Ya-ting, ZHANG Wei, WANG Yi-ying, HAO Han, ZHANG Hui-ran, ZHANG Hai-lin, DU Xiao-na. Research progress of PDI in amyotrophic lateral sclerosis[J]. Acta Pharmaceutica Sinica, 2021, 56(10): 2735-2741.

PDI在脊髓侧索硬化症中的研究进展
张永雪1,2, 蒲泽瑶1, 安亚婷1, 张薇1, 王艺颖1, 郝瀚1, 张会然1, 张海林1, 杜肖娜1*
1. 河北医科大学药理学教研室, 河北 石家庄 050017;
2. 邯郸市第一医院药学部, 河北 邯郸 056002
摘要:
蛋白质二硫键异构酶(protein disulfide isomerase,PDI,又称PDIA1)是蛋白质二硫键异构酶家族的原型蛋白,主要存在于内质网中,可以通过酶活性和分子伴侣功能帮助蛋白正确折叠,参与生理或病理过程。脊髓侧索硬化症(amyotrophic lateral sclerosis,ALS)是一种神经退行性疾病,以蛋白异常聚集为主要特征。近年来有研究者发现ALS患者有PDI突变体,并证实PDI蛋白在ALS疾病发生发展过程中有重要作用。本文重点综述PDI蛋白在ALS研究中的进展,以期为ALS疾病的治疗提供新靶点。
关键词:    蛋白质二硫键异构酶      分子伴侣      脊髓侧索硬化症      神经退行性疾病     
Research progress of PDI in amyotrophic lateral sclerosis
ZHANG Yong-xue1,2, PU Ze-yao1, AN Ya-ting1, ZHANG Wei1, WANG Yi-ying1, HAO Han1, ZHANG Hui-ran1, ZHANG Hai-lin1, DU Xiao-na1*
1. Department of Pharmacology, Hebei Medical University, Shijiazhuang 050017, China;
2. Department of Pharmacy, Handan First Hospital, Handan 056002, China
Abstract:
Protein disulfide isomerase (PDI), also named PDIA1, is an archetype member of protein disulfide isomerase family, which mainly exists in endoplasmic reticulum and plays an important role in pathophysiological progress via enzyme activity and molecular chaperone function helping protein folding correctly. Amyotrophic lateral sclerosis (ALS) is a kind of neurodegenerative diseases characterized by abnormal protein aggregation. Recently, PDI mutants have been found in ALS patients and the important role of PDI protein in the development of ALS has also been confirmed. Here, we focus on the recent studies of PDI in ALS hoping to provide a novel target for the treatment of ALS.
Key words:    protein disulfide isomerase    chaperone    amyotrophic lateral sclerosis    neurodegenerative disease   
收稿日期: 2021-05-08
DOI: 10.16438/j.0513-4870.2021-0686
基金项目: 国家自然科学基金资助项目(81870872);河北省教育厅在读研究生创新能力培养资助项目(CXZZBS2018074).
通讯作者: 杜肖娜,Tel:86-311-86266174,E-mail:du_xiaona@hotmail.com
Email: du_xiaona@hotmail.com
相关功能
PDF(446KB) Free
打印本文
0
作者相关文章
张永雪  在本刊中的所有文章
蒲泽瑶  在本刊中的所有文章
安亚婷  在本刊中的所有文章
张薇  在本刊中的所有文章
王艺颖  在本刊中的所有文章
郝瀚  在本刊中的所有文章
张会然  在本刊中的所有文章
张海林  在本刊中的所有文章
杜肖娜  在本刊中的所有文章

参考文献:
[1] Wang C, Li W, Ren J, et al. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase[J]. Antioxid Redox Signal, 2013, 19:36-45.
[2] Okumura M, Noi K, Kanemura S, et al. Dynamic assembly of protein disulfide isomerase in catalysis of oxidative folding[J]. Nat Chem Biol, 2019, 15:499-509.
[3] Neves RPP, Fernandes PA, Ramos MJ. Mechanistic insights on the reduction of glutathione disulfide by protein disulfide isomerase[J]. Proc Natl Acad Sci U S A, 2017, 114:E4724-E4733.
[4] Biterova EI, Isupov MN, Keegan RM, et al. The crystal structure of human microsomal triglyceride transfer protein[J]. Proc Natl Acad Sci U S A, 2019, 116:17251-17260.
[5] Wang CC, Tsou CL. Protein disulfide isomerase is both an enzyme and a chaperone[J]. FASEB J, 1993, 7:1515-1517.
[6] Hillson DA, Lambert N, Freedman RB. Formation and isomerization of disulfide bonds in proteins:protein disulfide-isomerase[J]. Methods Enzymol, 1984, 107:281-294.
[7] Tsai B, Rodighiero C, Lencer WI, et al. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin[J]. Cell, 2001, 104:937-948.
[8] Chen K, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets[J]. Blood, 1992, 79:2226-2228.
[9] Cook GM, Sousa C, Schaeffer J, et al. Regulation of nerve growth and patterning by cell surface protein disulphide isomerase[J]. Elife, 2020, 9:e54612.
[10] Yang YS, Harel NY, Strittmatter SM. Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis[J]. J Neurosci, 2009, 29:13850-13859.
[11] Bernardoni P, Fazi B, Costanzi A, et al. Reticulon1-C modulates protein disulphide isomerase function[J]. Cell Death Dis, 2013, 4:e581.
[12] Kaplan A, Gaschler MM, Dunn DE, et al. Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective[J]. Proc Natl Acad Sci U S A, 2015, 112:E2245-E2252.
[13] Hoffstrom BG, Kaplan A, Letso R, et al. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins[J]. Nat Chem Biol, 2010, 6:900-906.
[14] Lukesh JC, Andersen KA, Wallin KK, et al. Organocatalysts of oxidative protein folding inspired by protein disulfide isomerase[J]. Org Biomol Chem, 2014, 12:8598-8602.
[15] Halloran M, Parakh S, Atkin JD. The role of s-nitrosylation and s-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration[J]. Int J Cell Biol, 2013, 2013:797914.
[16] Walker AK, Farg MA, Bye CR, et al. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis[J]. Brain, 2010, 133:105-116.
[17] Jaiswal MK. Riluzole and edaravone:a tale of two amyotrophic lateral sclerosis drugs[J]. Med Res Rev, 2019, 39:733-748.
[18] Saitoh Y, Takahashi Y. Riluzole for the treatment of amyotrophic lateral sclerosis[J]. Neurodegener Dis Manag, 2020, 10:343-355.
[19] Yoshino H. Edaravone for the treatment of amyotrophic lateral sclerosis[J]. Expert Rev Neurother, 2019, 19:185-193.
[20] Kim G, Gautier O, Tassoni-Tsuchida E, et al. ALS genetics:gains, losses, and implications for future therapies[J]. Neuron, 2020, 108:822-842.
[21] Kwok CT, Morris AG, Frampton J, et al. Association studies indicate that protein disulfide isomerase is a risk factor in amyotrophic lateral sclerosis[J]. Free Radic Biol Med, 2013, 58:81-86.
[22] Yang Q, Guo ZB. Polymorphisms in protein disulfide isomerase are associated with sporadic amyotrophic lateral sclerosis in the Chinese Han population[J]. Int J Neurosci, 2016, 126:607-611.
[23] Gonzalez-Perez P, Woehlbier U, Chian RJ, et al. Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients[J]. Gene, 2015, 566:158-165.
[24] Woehlbier U, Colombo A, Saaranen MJ, et al. ALS-linked protein disulfide isomerase variants cause motor dysfunction[J]. EMBO J, 2016, 35:845-865.
[25] Parakh S, Shadfar S, Perri ER, et al. The redox activity of protein disulfide isomerase inhibits ALS phenotypes in cellular and zebrafish models[J]. iScience, 2020, 23:101097.
[26] Perri ER, Thomas CJ, Parakh S, et al. The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration[J]. Front Cell Dev Biol, 2015, 3:80.
[27] Jaronen M, Vehvilainen P, Malm T, et al. Protein disulfide isomerase in ALS mouse glia links protein misfolding with NADPH oxidase-catalyzed superoxide production[J]. Hum Mol Genet, 2013, 22:646-655.
[28] Renthal W, Tochitsky I, Yang L, et al. Transcriptional reprogramming of distinct peripheral sensory neuron subtypes after axonal injury[J]. Neuron, 2020, 108:128-144.
[29] Birsa N, Bentham MP, Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS[J]. Semin Cell Dev Biol, 2020, 99:193-201.
[30] Farg MA, Soo KY, Walker AK, et al. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase[J]. Neurobiol Aging, 2012, 33:2855-2868.
[31] Parakh S, Jagaraj CJ, Vidal M, et al. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis[J]. Hum Mol Genet, 2018, 27:1311-1331.
[32] Rozas P, Pinto C, Martinez Traub F, et al. Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS[J]. Acta Neuropathol Commun, 2021, 9:21.
[33] Aladesuyi Arogundade O, Nguyen S, Leung R, et al. Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization[J]. Acta Neuropathol Commun, 2021, 9:26.
[34] Kramer NJ, Haney MS, Morgens DW, et al. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity[J]. Nat Genet, 2018, 50:603-612.